GOSS · Categories · Form 4

GOSS - SEC Form 4 insider transactions

Gossamer Bio Inc. (GOSS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for GOSS

• 3d
  SEC Form 4 filed by Director Quisel John D

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 3d
  SEC Form 4 filed by Director Drynan Skye

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 3d
  SEC Form 4 filed by Director Daniel Thomas O

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 3d
  SEC Form 4 filed by Director Cox Russell J.

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 3d
  SEC Form 4 filed by Director Milligan Sandra

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 3d
  SEC Form 4 filed by Director Nathan Steven D

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 80d
  SEC Form 4 filed by Aranda Richard

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 80d
  SEC Form 4 filed by Peterson Caryn

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 80d
  SEC Form 4 filed by Smith Robert Paul Jr

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 80d
  SEC Form 4 filed by Hasnain Faheem

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 80d
  SEC Form 4 filed by Giraudo Bryan

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 80d
  SEC Form 4 filed by Christian Waage

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 154d
  President & CEO Hasnain Faheem was granted 280,000 shares, increasing direct ownership by 50% to 837,793 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 154d
  COO/CFO Giraudo Bryan was granted 115,750 shares, increasing direct ownership by 42% to 389,737 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 154d
  Chief Commercial Officer Smith Robert Paul Jr was granted 93,750 shares, increasing direct ownership by 56% to 260,898 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 154d
  Chief Medical Officer Aranda Richard was granted 93,750 shares, increasing direct ownership by 25% to 463,106 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 154d
  EVP, Regulatory Affairs Peterson Caryn was granted 84,500 shares, increasing direct ownership by 48% to 259,333 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 154d
  EVP, Tech Ops and Admin Christian Waage was granted 84,500 shares, increasing direct ownership by 12% to 814,061 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 249d
  Chief Commercial Officer Smith Robert Paul Jr was granted 162,500 shares (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 249d
  Chief Medical Officer Aranda Richard was granted 162,500 shares, increasing direct ownership by 79% to 369,356 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 249d
  EVP, Tech Ops and Admin Christian Waage was granted 125,000 shares, increasing direct ownership by 21% to 710,934 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 249d
  COO/CFO Giraudo Bryan was granted 181,250 shares, increasing direct ownership by 195% to 273,987 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 249d
  President & CEO Hasnain Faheem was granted 437,500 shares, increasing direct ownership by 364% to 557,793 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 249d
  EVP, Regulatory Affairs Peterson Caryn was granted 125,000 shares, increasing direct ownership by 251% to 174,833 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 347d
  SEC Form 4 filed by Director Daniel Thomas O

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 347d
  SEC Form 4 filed by Director Nathan Steven D

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 347d
  SEC Form 4 filed by Director Cox Russell J.

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 347d
  SEC Form 4 filed by Director Quisel John D

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 347d
  SEC Form 4 filed by Director Milligan Sandra

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 347d
  SEC Form 4 filed by Director Drynan Skye

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 459d
  SEC Form 4 filed by EVP, Regulatory Affairs Peterson Caryn

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 459d
  SEC Form 4 filed by EVP, Tech Ops and Admin Christian Waage

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 459d
  SEC Form 4 filed by Chief Commercial Officer Smith Robert Paul Jr

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 459d
  SEC Form 4 filed by Chief Medical Officer Aranda Richard

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 459d
  SEC Form 4 filed by COO/CFO Giraudo Bryan

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 459d
  SEC Form 4 filed by President & CEO Hasnain Faheem

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 713d
  Chief Medical Officer Aranda Richard sold $1,260 worth of shares (1,908 units at $0.66), decreasing direct ownership by 0.96% to 196,891 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 732d
  SEC Form 4 filed by Quisel John D

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 732d
  SEC Form 4 filed by Milligan Sandra

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 732d
  SEC Form 4 filed by Cox Russell J.

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 732d
  SEC Form 4 filed by Daniel Thomas O

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 802d
  Christian Waage sold $7,430 worth of shares (6,430 units at $1.16), decreasing direct ownership by 1% to 585,934 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 802d
  Giraudo Bryan sold $7,431 worth of shares (6,430 units at $1.16), decreasing direct ownership by 6% to 92,737 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 802d
  Hasnain Faheem sold $26,773 worth of shares (23,172 units at $1.16), decreasing direct ownership by 16% to 120,293 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 811d
  Aranda Richard sold $5,342 worth of shares (4,018 units at $1.33), decreasing direct ownership by 2% to 198,799 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 811d
  Peterson Caryn sold $5,343 worth of shares (4,018 units at $1.33), decreasing direct ownership by 7% to 49,833 units (SEC Form 4)

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 818d
  SEC Form 4 filed by Drynan Skye

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 818d
  SEC Form 4 filed by Nathan Steven D

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 886d
  SEC Form 4 filed by Peterson Caryn

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 886d
  SEC Form 4 filed by Christian Waage

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 886d
  SEC Form 4 filed by Aranda Richard

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 886d
  SEC Form 4 filed by Giraudo Bryan

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 886d
  SEC Form 4 filed by Hasnain Faheem

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 916d
  SEC Form 4 filed by Smith Robert Paul Jr

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 922d
  SEC Form 4 filed by Quisel John D

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 929d
  SEC Form 4 filed by Aranda Richard

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 929d
  SEC Form 4 filed by Giraudo Bryan

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 929d
  SEC Form 4 filed by Peterson Caryn

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 929d
  SEC Form 4 filed by Hasnain Faheem

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)
• 929d
  SEC Form 4 filed by Christian Waage

  4 - Gossamer Bio, Inc. (0001728117) (Issuer)

Other GOSS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends